Position in ESPR
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$0
+$0 QoQ
Shares Held
523
+946.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $131,747,740 across 34 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
158,184 | $85,708,836 | |
| 2 | ZTS |
Zoetis Inc.
|
112,370 | $8,074,908 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
288,888 | $7,109,533 | |
| 4 | VTRS |
Viatris Inc
|
411,537 | $6,535,207 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
30,217 | $5,092,773 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
59,330 | $2,804,529 | |
| 7 | LQDA |
Liquidia Corp
|
35,159 | $2,803,227 | |
| 8 | HLN |
Haleon plc
|
217,576 | $2,029,984 |
All Filings in ESPR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 523 | Shares | Defined | 2026-05-01 | |
| 2021-09-30 | — | 50 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | — | 50 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | — | 50 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | — | 50 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | — | 50 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | — | 50 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | — | 50 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||